Combination EGFR and RET Inhibition in Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC

Saved in:
Bibliographic Details
Published inThe Annals of pharmacotherapy Vol. 56; no. 4; p. 503
Main Authors Freydman, Jessica, Henshaw, Lynnette, Patel, Jasmine V, Smith, Claire E, Everett, Peter C
Format Journal Article
LanguageEnglish
Published United States 01.04.2022
Subjects
Acrylamides - pharmacology
Acrylamides - therapeutic use
Aniline Compounds - pharmacology
Aniline Compounds - therapeutic use
Drug Resistance, Neoplasm - genetics
ErbB Receptors - genetics
Humans
Lung Neoplasms - drug therapy
Lung Neoplasms - genetics
Mutation
Protein Kinase Inhibitors - pharmacology
Protein Kinase Inhibitors - therapeutic use
Proto-Oncogene Proteins c-ret
Online AccessGet more information

Cover

More Information
ISSN:1542-6270
DOI:10.1177/10600280211036909